$AUBN
AUBURN NATIONAL BANCORPORATION, INC

2023 Q2 Form 10-Q Financial Statement

#000119312523136824 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $154.0K $154.0K $6.668M
YoY Change -97.78% -97.69% 0.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $435.0K $423.0K $240.0K
YoY Change 11.25% 76.25% -20.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.505M $1.126M $590.0K
YoY Change 170.2% 90.85% -11.94%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.216M $2.231M $2.335M
YoY Change 2.4% -4.45% -3.87%
Income Tax $288.0K $267.0K $254.0K
% Of Pretax Income 13.0% 11.97% 10.88%
Net Earnings $1.928M $1.964M $2.081M
YoY Change 7.05% -5.62% 3.74%
Net Earnings / Revenue 1251.95% 1275.32% 31.21%
Basic Earnings Per Share $0.55 $0.56 $0.59
Diluted Earnings Per Share $0.55 $0.56 $590.9K
COMMON SHARES
Basic Shares Outstanding 3.500M shares 3.501M shares 3.519M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $29.54M $25.86M $189.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $45.90M $46.22M $42.12M
YoY Change 1.25% 9.73% 52.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.40M $12.20M
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.026B $1.018B $1.110B
YoY Change -5.36% -8.28% 11.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $2.245M $2.459M $1.500M
YoY Change 72.83% 63.93% -73.68%
Deferred Revenue
YoY Change
Short-Term Debt $2.167M $2.457M $4.000M
YoY Change -47.75% -38.58% 21.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.412M $4.916M $1.500M
YoY Change 239.65% 227.73% -73.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.412M $4.916M $1.500M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $955.2M $944.1M $1.023B
YoY Change -5.26% -7.73% 15.02%
SHAREHOLDERS EQUITY
Retained Earnings $117.8M $116.8M $111.1M
YoY Change 5.17% 5.11% 4.15%
Common Stock $3.839M $3.837M $3.834M
YoY Change 0.1% 0.08% 0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.57M $11.54M $11.09M
YoY Change 2.38% 4.03% 18.57%
Treasury Stock Shares 457.7K shares 456.3K shares
Shareholders Equity $70.98M $73.64M $86.40M
YoY Change
Total Liabilities & Shareholders Equity $1.026B $1.018B $1.110B
YoY Change -5.36% -8.28% 11.72%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.928M $1.964M $2.081M
YoY Change 7.05% -5.62% 3.74%
Depreciation, Depletion And Amortization $435.0K $423.0K $240.0K
YoY Change 11.25% 76.25% -20.0%
Cash From Operating Activities $2.484M $4.891M $2.007M
YoY Change 14.58% 143.7% -65.77%
INVESTING ACTIVITIES
Capital Expenditures $35.00K $5.000K -$550.0K
YoY Change -101.0% -100.91% -90.14%
Acquisitions
YoY Change
Other Investing Activities -$9.051M $5.966M $8.870M
YoY Change -76.85% -32.74% -127.62%
Cash From Investing Activities -$9.086M $5.961M $8.318M
YoY Change -78.67% -28.34% -122.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $120.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.28M -$12.25M $22.99M
YoY Change -164.15% -153.28% -43.67%
NET CHANGE
Cash From Operating Activities 2.484M $4.891M $2.007M
Cash From Investing Activities -9.086M $5.961M $8.318M
Cash From Financing Activities 10.28M -$12.25M $22.99M
Net Change In Cash 3.680M -$1.398M $33.32M
YoY Change -106.52% -104.2% 270.53%
FREE CASH FLOW
Cash From Operating Activities $2.484M $4.891M $2.007M
Capital Expenditures $35.00K $5.000K -$550.0K
Free Cash Flow $2.449M $4.886M $2.557M
YoY Change -56.86% 91.08% -77.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
311371000 usd
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
635026000 usd
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
638966000 usd
CY2023Q1 us-gaap Deposits
Deposits
939190000 usd
CY2022Q4 us-gaap Deposits
Deposits
950337000 usd
CY2023Q1 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
2457000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
2959000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
955847000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
39000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
39000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3798000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1023888000 usd
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8500000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3957135 shares
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000750574
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Entity File Number
EntityFileNumber
0-26486
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Auburn National Bancorporation, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
63-0885779
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 N. Gay Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Auburn
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
36830
CY2023Q1 dei City Area Code
CityAreaCode
334
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
821-9200
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
CY2023Q1 dei Trading Symbol
TradingSymbol
AUBN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3500376 shares
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
17083000 usd
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11608000 usd
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
1951000 usd
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
9300000 usd
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
6822000 usd
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
6346000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25856000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27254000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
405692000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
405304000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
505041000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
504458000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6821000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
5765000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
498220000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
498693000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46222000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46575000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
19893000 usd
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
19952000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
21863000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
26110000 usd
CY2023Q1 us-gaap Assets
Assets
1017746000 usd
CY2022Q4 us-gaap Assets
Assets
1023888000 usd
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
304164000 usd
CY2022Q4 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
2551000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
2459000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
944106000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
8500000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3957135 shares
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3797000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
116798000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
116600000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35457000 usd
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1865000 usd
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1336000 usd
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
403000 usd
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
419000 usd
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
213000 usd
CY2022Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
63000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8235000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6668000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40920000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
456256 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
453683 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
11538000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11475000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
73640000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68041000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1017746000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5754000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4850000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1118000 usd
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
585000 usd
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
8000 usd
CY2022Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
5000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1126000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
590000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7109000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6078000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
66000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-250000 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7043000 usd
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6328000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
66000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-250000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
142000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
93000 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
253000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
156000 usd
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
99000 usd
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
389000 usd
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
414000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
792000 usd
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
908000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2927000 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2950000 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
799000 usd
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
434000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
338000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
230000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1540000 usd
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1287000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
5604000 usd
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
4901000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2231000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2335000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
267000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
254000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1964000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2081000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3502143 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3518657 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1964000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2081000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5463000 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18346000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5463000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18346000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7427000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16265000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68041000 usd
CY2023Q1 aubn Cumulative Effect Of Change In Accounting Standard
CumulativeEffectOfChangeInAccountingStandard
821000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1964000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5463000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.27
CY2023Q1 aubn Cash Dividends Paid
CashDividendsPaid
-945000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
64000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
2000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
73640000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103726000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2081000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18346000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.265
CY2022Q1 aubn Cash Dividends Paid
CashDividendsPaid
-932000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
120000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
2000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
86411000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
423000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
244000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-612000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1964000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2081000 usd
CY2023Q1 aubn Impact Of Adoption Of Asc326
ImpactOfAdoptionOfAsc326
1019000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-909000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
4000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
229000 usd
CY2023Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
0 usd
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
5792000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
6366000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
104000 usd
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
99000 usd
CY2023Q1 aubn Income Recognized On Death Benefit Of Life Insurance
IncomeRecognizedOnDeathBenefitOfLifeInsurance
52000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4420000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5161000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-2434000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
3938000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4891000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2007000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
6296000 usd
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19523000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
40498000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
586000 usd
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-29916000 usd
CY2023Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
5000 usd
CY2022Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
549000 usd
CY2023Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
215000 usd
CY2023Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-41000 usd
CY2022Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
74000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5961000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8318000 usd
CY2023Q1 us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
-7207000 usd
CY2022Q1 us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
-7794000 usd
CY2023Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
-3940000 usd
CY2022Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
31293000 usd
CY2023Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
-94000 usd
CY2022Q1 us-gaap Increase Decrease In Federal Funds Purchased And Securities Sold Under Agreements To Repurchase Net
IncreaseDecreaseInFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchaseNet
546000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
64000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
120000 usd
CY2023Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
945000 usd
CY2022Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
932000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12250000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22993000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1398000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
33318000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27254000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156259000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25856000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189577000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
877000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
609000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
11000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<div id="TextBlockContainer189" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:663px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">General </div><div id="a2589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Auburn National Bancorporation, Inc. (the “Company”) provides a full range of banking services<div style="display:inline-block;width:5px"> </div>to individuals and </div><div id="a2593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">commercial customers in Lee County,<div style="display:inline-block;width:5px"> </div>Alabama and surrounding areas through its wholly owned subsidiary,<div style="display:inline-block;width:6px"> </div>AuburnBank </div><div id="a2600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">(the “Bank”). The Company does not have any segments other than banking that are considered<div style="display:inline-block;width:5px"> </div>material.</div></div>
CY2023Q1 us-gaap Reclassifications
Reclassifications
<div id="TextBlockContainer203" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:649px;height:59px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Reclassifications</div><div id="a2786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:27px;">Certain amounts reported in prior periods have been reclassified to conform to the current<div style="display:inline-block;width:1px"> </div>-period presentation. These </div><div id="a2789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:43px;">reclassifications had no material effect on the Company’s<div style="display:inline-block;width:5px"> </div>previously reported net earnings or total stockholders’ equity.</div></div>
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1000000.0 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
100000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
26000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
300000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1964000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2081000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3502143 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3518657 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5600000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
68013000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
105065000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
227014000 usd
CY2023Q1 aubn Available For Sale Securities Fair Value
AvailableForSaleSecuritiesFairValue
405692000 usd
CY2023Q1 aubn Available For Sale Securities Gross Unrealized Gains2
AvailableForSaleSecuritiesGrossUnrealizedGains2
49000 usd
CY2023Q1 aubn Available For Sale Securities Gross Unrealized Losses
AvailableForSaleSecuritiesGrossUnrealizedLosses
47396000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
453039000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5235000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
58518000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
112219000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
229332000 usd
CY2022Q4 aubn Available For Sale Securities Fair Value
AvailableForSaleSecuritiesFairValue
405304000 usd
CY2022Q4 aubn Available For Sale Securities Gross Unrealized Gains2
AvailableForSaleSecuritiesGrossUnrealizedGains2
11000 usd
CY2022Q4 aubn Available For Sale Securities Gross Unrealized Losses
AvailableForSaleSecuritiesGrossUnrealizedLosses
54653000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
459946000 usd
CY2023Q1 aubn Costmethodsecurtiesinvestmentcarryingamount
Costmethodsecurtiesinvestmentcarryingamount
1200000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
60576000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2275000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
337230000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
45121000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
397806000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
47396000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
171001000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
12179000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
230596000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
42474000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
401597000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
54653000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
505041000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
504458000 usd
CY2023Q1 aubn Financing Receivable Recorded Investment Total Still Accruing
FinancingReceivableRecordedInvestmentTotalStillAccruing
502361000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2680000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
505041000 usd
CY2022Q4 aubn Financing Receivable Recorded Investment Total Still Accruing
FinancingReceivableRecordedInvestmentTotalStillAccruing
501727000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2731000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
504458000 usd
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
34996000 usd
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
183353000 usd
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
90751000 usd
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
62057000 usd
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
42905000 usd
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
77452000 usd
CY2023Q1 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
13527000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
505041000 usd
CY2023Q1 aubn Financing Receivable Excluding Accrued Interest Year Two Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedCurrentFiscalYearWriteoff
6000 usd
CY2023Q1 aubn Financing Receivable Excluding Accrued Interest Year Three Originated Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedCurrentFiscalYearWriteoff
5000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
11000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2731000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
504458000 usd
CY2023Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
1176000 usd
CY2023Q1 aubn Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
1504000 usd
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2680000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2731000 usd
CY2023Q1 aubn Financing Receivable Individually Evaluated Collateral Depedent Loans
FinancingReceivableIndividuallyEvaluatedCollateralDepedentLoans
2535000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5765000 usd
CY2023Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
40000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6821000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4939000 usd
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-250000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4658000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4658000 usd
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4658000 usd
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
428749000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0 usd
CY2022Q1 aubn Financing Receivable Individually Evaluated Collateral Depedent Loans
FinancingReceivableIndividuallyEvaluatedCollateralDepedentLoans
182000 usd
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
182000 usd
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4658000 usd
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
428931000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
1068000 usd
CY2022Q4 aubn Impaired Financing Receivable With No Related Allowance Charge Off And Payments Applied
ImpairedFinancingReceivableWithNoRelatedAllowanceChargeOffAndPaymentsApplied
-4000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
1064000 usd
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
1495000 usd
CY2022Q4 aubn Impaired Financing Receivable With Related Allowance Charge Off And Payments Applied
ImpairedFinancingReceivableWithRelatedAllowanceChargeOffAndPaymentsApplied
0 usd
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
1495000 usd
CY2022Q4 aubn Impaired Financing Receivable With Related Allowance Related Allowance
ImpairedFinancingReceivableWithRelatedAllowanceRelatedAllowance
505000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2563000 usd
CY2022Q4 aubn Impaired Financing Receivable Charge Off And Payments Applied
ImpairedFinancingReceivableChargeOffAndPaymentsApplied
-4000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
2559000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
505000 usd
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
251000 usd
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
0 usd
CY2022Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1151000 usd
CY2021Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1309000 usd
CY2023Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
0 usd
CY2022Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
54000 usd
CY2023Q1 aubn Servicing Asset At Amortized Value Amortization2
ServicingAssetAtAmortizedValueAmortization2
-55000 usd
CY2022Q1 aubn Servicing Asset At Amortized Value Amortization2
ServicingAssetAtAmortizedValueAmortization2
-78000 usd
CY2023Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1096000 usd
CY2022Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1285000 usd
CY2022Q4 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2021Q4 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2022Q4 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2023Q1 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2022Q4 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2022Q4 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2022Q1 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
0 usd
CY2022Q4 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
2369000 usd
CY2021Q4 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
1908000 usd
CY2023Q1 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
2419000 usd
CY2022Q1 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
2277000 usd
CY2023Q1 aubn Collateral Dependent Loan Recorded Investment Paid In Full
CollateralDependentLoanRecordedInvestmentPaidInFull
1300000 usd
CY2023Q1 aubn Collateral Dependent Loan Recorded Investment Paid In Full Related Allowance
CollateralDependentLoanRecordedInvestmentPaidInFullRelatedAllowance
500000 usd

Files In Submission

Name View Source Status
0001193125-23-136824-index-headers.html Edgar Link pending
0001193125-23-136824-index.html Edgar Link pending
0001193125-23-136824.txt Edgar Link pending
0001193125-23-136824-xbrl.zip Edgar Link pending
aubn-20230331.xsd Edgar Link pending
d467207d10q.htm Edgar Link pending
d467207dex311.htm Edgar Link pending
d467207dex312.htm Edgar Link pending
d467207dex321.htm Edgar Link pending
d467207dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
aubn-20230331_cal.xml Edgar Link unprocessable
aubn-20230331_def.xml Edgar Link unprocessable
aubn-20230331_lab.xml Edgar Link unprocessable
aubn-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d467207d10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending